The critical need for cancer biometrics: quantitative, reproducible measures of cancer to define response to therapy.

MLA

Lotze, Michael T. “The Critical Need for Cancer Biometrics: Quantitative, Reproducible Measures of Cancer to Define Response to Therapy.” Current Opinion in Investigational Drugs (London, England : 2000), vol. 4, no. 6, June 2003, pp. 649–51. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=cmedm&AN=12901221&authtype=sso&custid=ns315887.

APA

Lotze, M. T. (2003). The critical need for cancer biometrics: quantitative, reproducible measures of cancer to define response to therapy. Current Opinion in Investigational Drugs (London, England : 2000), 4(6), 649–651.

Chicago

Lotze, Michael T. 2003. “The Critical Need for Cancer Biometrics: Quantitative, Reproducible Measures of Cancer to Define Response to Therapy.” Current Opinion in Investigational Drugs (London, England : 2000) 4 (6): 649–51. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=cmedm&AN=12901221&authtype=sso&custid=ns315887.